Compromised hemodynamic response in amyloid precursor protein transgenic mice

Journal of Neuroscience

Volumn 22, Issue 16, 2002, Pages 7218-7224

  Mueggler, Thomas ^a   Sturchler Pierrat, Christine ^b   Baumann, Diana ^a   Rausch, Martin ^a   Staufenbiel, Matthias ^b   Rudin, Markus ^a,b  

^a Central Technologies   (Switzerland)

^b NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Acetazolamide; Amyloid precursor protein (APP); Functional magnetic resonance imaging (fMRI); GABAA antagonist; PtcCO2; Transgenic mice; amyloid

Indexed keywords

AMYLOID PRECURSOR PROTEIN; BICUCULLINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL REACTIVITY; BRAIN ISCHEMIA; BRAIN MAPPING; CONTROLLED STUDY; DIAGNOSTIC IMAGING; HEMODYNAMICS; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; TRANSGENIC MOUSE;

EID: 0037104754     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.22-16-07218.2002     Document Type: Article

References (47)

1. Alsop DC, Detre JA, Grossman M (2000) Assessment of cerebral blood flow in Alzheimer's disease by spin-labeled magnetic resonance imaging. Ann Neurol 47:93-100.
2. Bobinski M, De Leon MJ, Convit A, De Santi S, Wegiel J, Tarshish CY, Saint LL, Wisniewski HM (1999) MRI of entorhinal cortex in mild Alzheimer's disease. Lancet 353:38-40.
3. Bookheimer SY, Stroiwas MH, Cohen MS, Saunders AM, Pericak-Vance MA, Mazziotta JC, Small GW (2000) Patterns of brain activation in people at risk for Alzheimer's disease. N Engl J Med 343:450-456.
4. Brunetti A, Postiglione A, Tedeschi E, Ciarmiello A, Quarantelli M, Covelli EM, Milan G, Larobina M, Soricelli A, Sodano A, Alfano B (2000) Measurement of global brain atrophy in Alzheimer's disease with unsupervised segmentation of spin-echo MRI studies. J Magn Reson Imaging 11:260-266.
5. Calhoun ME, Burgermeister P, Phinney AL, Stalder M, Tolnay M, Wiederhold KH, Abramowski D, Sturchler-Pierrat C, Sommer B, Staufenbiel M, Jucker M (1999) Neuronal overexpression of mutant amyloid precursor protein results in prominent deposition of cerebrovascular amyloid. Proc Natl Acad Sci USA 96:14088-14093.
6. Christie R, Yamada M, Moskowitz M, Hyman B (2001) Structural and functional disruption of vascular smooth muscle cells in a transgenic mouse model of amyloid angiopathy. Am J Pathol 158:1065-1071.
7. Csete K, Barzo P, Bodosi M, Papp JG (2001) Influence of nitrovasodilators and cyclooxygenase inhibitors on cerebral vasoreactivity in conscious rabbits. Eur J Pharmacol 412:301-309.
8. De Toledo-Morrell L, Goncharova I, Dickerson B, Wilson RS, Bennett DA (2000) From healthy aging to early Alzheimer's disease: In vivo detection of entorhinal cortex atrophy. Ann NY Acad Sci 911:240-253.
9. Fox NC, Warrington EK, Rossor MN (1999) Serial magnetic resonance imaging of cerebral atrophy in preclinical Alzheimer's disease. Lancet 353:2125.
10. Gambhir S, Inao S, Tadokoro M, Nishino M, Ito K, Ishigaki T, Kuchiwaki H, Yoshida J (1997) Comparison of vasodilatory effect of carbon dioxide inhalation and intravenous acetazolamide on brain vasculature using positron emission tomography. Neurol Res 19:139-144.
11. Geula C, Mesulam M (1989) Special properties of cholinesterases in the cerebral cortex of Alzheimer's disease. Brain Res 498:185-189.
12. Ghandour MS, Langley OK, Zhu XL, Waheed A, Sly WS (1992) Carbonic anhydrase IV on brain capillary endothelial cells: A marker associated with the blood-brain barrier. Proc Natl Acad Sci USA 89:6823-6827.
13. Greenberg SM, Rebeck GW, Vonsattel JP, Gomez-Isla T, Hyman BT (1995) Apolipoprotein E ε4 and cerebral hemorrhage associated with amyloid angiopathy. Ann Neurol 38:254-259.
14. Grossmann WM, Koeberle B (2000) The dose-response relationship of acetazolamide on the cerebral blood flow in normal subjects. Cerebrovasc Dis 10:65-69.
15. Harris GJ, Lewis RF, Satlin A, English CD, Scott TM, Yurgelun-Todd DA, Renshaw PF (1998) Dynamic susceptibility contrast MR imaging of regional cerebral blood volume in Alzheimer disease: A promising alternative to nuclear medicine. AJNR Am J Neuroradiol 19:1727-1732.
16. Hennig J, Nauerth A, Friedburg H (1986) RARE imaging: A fast imaging method for clinical MR. Magn Reson Med 3:823-833.
17. Hirono N, Kitagaki H, Kazui H, Hashimoto M, Mori E (2000) Impact of white matter changes on clinical manifestation of Alzheimer's disease: A quantitative study. Stroke 31:2182-2188.
18. Iadecola C, Zhang F, Niwa K, Eckman C, Turner SK, Fischer E, Younkin S, Borchelt DR, Hsiao KK, Carlson GA (1999) SOD1 rescues cerebral endothelial dysfunction in mice overexpressing amyloid precursor protein. Nat Neurosci 2:157-161.
19. Johnson SC, Saykin AJ, Baxter LC, Flashman LA, Santulli RB, McAllister TW, Mamourian AC (2000) The relationship between fMRI activation and cerebral atrophy: Comparison of normal aging and Alzheimer disease. Neurolmage 11:179-187.
20. Kohshi K, Konda N, Kinoshita Y, Tsuru E, Yokota A (1994) In situ arterial and brain tissue PCO2 responses to acetazolamide in cats. J Appl Physiol 76:2199-2203.
21. Laakso MP, Frisoni GB, Kononen M, Mikkonen M, Beltramello A, Geroldi C, Bianchetti A, Trabucchi M, Soininen H, Aronen HJ (2000) Hippocampus and entorhinal cortex in frontotemporal dementia and Alzheimer's disease: A morphometric MRI study. Biol Psychiatry 47:1056-1063.
22. Maas LC, Harris GJ, Satlin A, English CD, Lewis RF, Renshaw PF (1997) Regional cerebral blood volume measured by dynamic susceptibility contrast MR imaging in Alzheimer's disease: A principal components analysis. J Magn Reson Imaging 7:215-219.
23. Maren TH (1967) Carbonic anhydrase: Chemistry, physiology, and inhibition. Physiol Rev 47:595-781.
24. Maren TH (1977) Use of inhibitors in physiological studies of carbonic anhydrase. Am J Physiol 232:F291-F297.
25. Mueggler T, Baumann D, Rausch M, Rudin M (2001) Bicuculline-induced brain activation in mice detected by magnetic resonance imaging. Magn Reson Med 46:292-298.
26. Niwa K, Carlson GA, Iadecola C (2000a) Exogenous Aβ1-40 reproduces cerebrovascular alterations resulting from amyloid precursor protein overexpression in mice. J Cereb Blood Flow Metab 20:1659-1668.
27. Niwa K, Younkin L, Ebeling C, Turner SK, Westaway D, Younkin S, Ashe KH, Carlson GA, Iadecola C (2000b) Aβ1-40-related reduction in functional hyperemia in mouse neocortex during somatosensory activation. Proc Natl Acad Sci USA 97:9735-9740.
28. Phinney AL, Deller T, Stalder M, Calhoun ME, Frotscher M, Sommer B, Staufenbiel M, Jucker M (1999) Cerebral amyloid induces aberrant axonal sprouting and ectopic terminal formation in amyloid precursor protein transgenic mice. J Neurosci 19:8552-8559.
29. Probst A, Langui D, Ulrich J (1991) Alzheimer's disease: A description of the structural lesions. Brain Pathol 1:229-239.
30. Reese T, Bjelke B, Porszasz R, Baumann D, Bochelen D, Sauter A, Rudin M (2000) Regional brain activation by bicuculline visualized by functional magnetic resonance imaging. Time-resolved assessment of bicuculline-induced changes in local cerebral blood volume using an intravascular contrast agent. NMR Biomed 13:43-49.
31. Ridderstrale Y, Hanson M (1985) Histochemical study of the distribution of carbonic anhydrase in the cat brain. Acta Physiol Scand 124:557-564.
32. Rombouts SA, Barkhof F, Witter MP, Scheltens P (2000) Unbiased whole-brain analysis of gray matter loss in Alzheimer's disease. Neurosci Lett 285:231-233.
33. Rosen GD (2000) The mouse brain library. International Mouse Genome Conference, Narita, Japan. 14:166.
34. Roth LJ, Schoolar JC, Barlow CF (1959) Sulfur-35 labeled acetazolamide in cat brain. J Pharmacol Exp Ther 125:128-136.
35. Sandson TA, O'Connor M, Sperling RA, Edelman RR, Warach S (1996) Noninvasive perfusion MRI in Alzheimer's disease: A preliminary report. Neurology 47:1339-1342.
36. Severinghaus JW (1965) Handbook of Physiology. III. Respiration. Baltimore: Williams and Wilkins.
37. Severinghaus JW (1982) Transcutaneous blood gas analysis. Resp Care 27:152-159.
38. Siggaard-Andersen O (1965) The Acid-Base Status of the Blood. Baltimore: Williams and Wilkins.
39. Sommer B, Sturchler-Pierrat C, Abramowski D, Wiederhold KH, Calhoun M, Jucker M, Kelly P, Staufenbiel M (2000) Transgenic approaches to model Alzheimer's disease. Rev Neurosci 11:47-51.
40. Staufenbiel M, Sturchler-Pierrat C, Abramowski D, Duke M, Wiederhold KH, Mistl C, Rothacher S, Ledermann B, Buerki K, Frey P, Paganetti PA, Waridel C, Calhoun M, Jucker M, Probst A, Sommer B (1997) Pathological features in APP transgenic mice resembling those of Alzheimer's disease. In: Alzheimer's Disease, Vol II (Friedmann E, Savage LM, eds), pp 4.2.1-4.2.12. Southborough, MA: International Business Communications IBC.
41. Sturchler-Pierrat C, Staufenbiel M (2000) Pathogenic mechanisms of Alzheimer's disease analyzed in the APP23 transgenic mouse model. Ann NY Acad Sci 920:134-139.
42. Sturchler-Pierrat C, Abramowski D, Duke M, Wiederhold KH, Mistl C, Rothacher S, Ledermann B, Burki K, Frey P, Paganetti PA, Waridel C, Calhoun ME, Jucker M, Probst A, Staufenbiel M, Sommer B (1997) Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology. Proc Natl Acad Sci USA 94:13287-13292.
43. Tago H, McGeer PL, McGeer EG (1987) Acetylcholinesterase fibers and the development of senile plaques. Brain Res 406:363-369.
44. Tanabe JL, Amend D, Schuff N, DiSclafani V, Ezekiel F, Norman D, Fein G, Weiner MW (1997) Tissue segmentation of the brain in Alzheimer disease. AJNR Am J Neuroradiol 18:115-123.
45. Thulborn KR, Martin C, Voyvodic JT (2000) Functional MR imaging using a visually guided saccade paradigm for comparing activation patterns in patients with probable Alzheimer's disease and in cognitively able elderly volunteers. AJNR Am J Neuroradiol 21:524-531.
46. Vorstrup S, Henriksen L, Paulson OB (1984) Effect of acetazolamide on cerebral blood flow and cerebral metabolic rate for oxygen. J Clin Invest 74:1634-1639.
47. Winkler DT, Bondolfi L, Herzig MC, Jann L, Calhoun ME, Wiederhold KH, Tolnay M, Staufenbiel M, Jucker M (2001) Spontaneous hemorrhagic stroke in a mouse model of cerebral amyloid angiopathy. J Neurosci 21:1619-1627.